Translating Discovery to Therapy

February 20-22, 2025

The conference will bring together clinicians, researchers, and young investigators to present and discuss current approaches and future directions for translating science to therapy for incontinentia pigmenti (IP). Our goal is to advance our ability to diagnose and manage this rare disease through the development of screening guidelines, effective diagnostics, and novel therapies.

IP Diagnosis and Screening

Family Burden – Patient Perspective

Clinical Features of Disease

Sight Threatening Complications

Current Practices and Treatment Protocols

Genetic Aspects of Disease

Molecular Pathways

Development of Novel Therapies

Conference Speakers and Participants

Internationally recognized clinicians, researchers, and young investigators with expertise in developing and applying novel treatments in relationship to IP. Early career investigators are defined as postdoctoral fellows, graduate students, junior faculty (less than 10 years from obtaining terminal degree), and residents.

J. Peter Campbell, MD, MPH

Becky M. Abbott, MPH

Mary Fete MSN, RN, CCM

Connie Chen, MD

Mary Elizabeth Hartnett, MD

Ian Han, MD

Sandra Montezuma, MD

Dorthy Katherine Grange, MD

Reid Wilson, MD, PhD

Aliyah King, BA

Phillip Ehrich

Nancy Arias, MD

Eric Van Otterloo, PhD

Nicole Somani, MD, MPH

Maddison Salois, BS

Saravanan Thangarajan, MDS, MBA

Shirley Parraga, BS

Markus Schwaninger, MD

Emily Cole, MD, MPH

Jacques Monnet

Teresa Faupel

Susanne Emmerich

Jeremie Rosain PhD

Timothy Wright, DDS, MS

Morton F. Goldberg, MD

Audine Berrocal, MD

Xi Chen, MD, PhD

Philip Ferrone, MD

Eric Nudleman, MD, PhD

Registration

Closed

Conference Location

Embassy Suites by Hilton Charlotte Uptown

The conference will be a hybrid meeting with the keynote speakers and key researchers/clinicians present onsite with others invited to participate virtually.

For More Information

Contact Mary Fete, M.S.N., R.N., C.C.M. at 618-566-2020 or mary@nfed.org.

Download Conference Flyer